Quipt Home Medical Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QIPT research report →
Companyquipthomemedical.com
Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions.
- CEO
- Gregory John Crawford
- IPO
- 2010
- Employees
- 1,200
- HQ
- Wilder, KY, US
Price Chart
Valuation
- Market Cap
- $162.30M
- P/E
- -14.81
- P/S
- 0.00
- P/B
- 1.57
- EV/EBITDA
- 2.06
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 72.38%
- Op Margin
- -0.21%
- Net Margin
- -4.03%
- ROE
- -10.47%
- ROIC
- -0.24%
Growth & Income
- Revenue
- $341.40M · 38.83%
- Net Income
- $-10,701,000 · -58.23%
- EPS
- $-0.25 · -56.25%
- Op Income
- $-5,319,513
- FCF YoY
- 1.08%
Performance & Tape
- 52W High
- $3.65
- 52W Low
- $1.35
- 50D MA
- $3.60
- 200D MA
- $2.74
- Beta
- 0.49
- Avg Volume
- 447.00K
Get TickerSpark's AI analysis on QIPT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 16, 26 | Wessel Brian Joseph | sell | 75,000 |
| Mar 16, 26 | Wessel Brian Joseph | sell | 98,875 |
| Mar 16, 26 | Roehrig Thomas | sell | 173,000 |
| Mar 16, 26 | Roehrig Thomas | sell | 50,000 |
| Mar 16, 26 | Roehrig Thomas | sell | 50,000 |
| Mar 16, 26 | Roehrig Thomas | sell | 30,000 |
| Mar 16, 26 | Miles Mark Alan | sell | 110,000 |
| Mar 16, 26 | Miles Mark Alan | sell | 12,500 |
| Mar 16, 26 | Miles Mark Alan | sell | 30,000 |
| Mar 16, 26 | Miles Mark Alan | sell | 15,000 |
Our QIPT Coverage
We haven't published any research on QIPT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QIPT Report →